The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- ‘A slippery slope’: Is AI eroding clinical skills? (Healio)
- ModMed Expands gGastro Suite With New AI Capabilities for Gastroenterology (Business Wire)
- CRH Anesthesia Announces Partnership with Associates in Gastroenterology Through Acquisition of Majority Interest in Southern Colorado Anesthesia Associates (CRH Medical)
- Bidirectional Text Navigation (ColoPrep) Increases Colonoscopy Show Rate (Gastro Hep Advances)
- Viome Launches CancerDetect® Pancreatic, Built For Early Pancreatic Cancer Detection (PR Newswire)
- Magnetically controlled capsule shows promise for investigating hard-to-reach regions of the small intestine (Medical Xpress)
- Successful Repeat Colonoscopy and Building an AI Databank (GI & Endoscopy News)
- What created GI’s anesthesia ‘dependency’ — and what comes next (Becker’s Healthcare)
